Suppr超能文献

心脏生物酶在预测2019冠状病毒病心血管结局中的应用

Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.

作者信息

Gulmez Ali Osman, Aydin Sonay

机构信息

Department of Radiology, Erzincan University, Erzincan 24100, Turkey.

出版信息

World J Virol. 2023 Mar 25;12(2):132-135. doi: 10.5501/wjv.v12.i2.132.

Abstract

The relationship between coronavirus disease-19 (COVID-19) and cardiovascular diseases has been an important issue. Therefore, cardiac biomarkers and cardiac imaging have an important place in the diagnostic phase. It is important to know the relationship of biomarkers in COVID-19 so that we can understand the diagnosis of the disease, the predicted course and results after diagnosis.

摘要

冠状病毒病-19(COVID-19)与心血管疾病之间的关系一直是一个重要问题。因此,心脏生物标志物和心脏成像在诊断阶段具有重要地位。了解COVID-19中生物标志物的关系非常重要,这样我们才能理解该疾病的诊断、预测病程以及诊断后的结果。

相似文献

1
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.
World J Virol. 2023 Mar 25;12(2):132-135. doi: 10.5501/wjv.v12.i2.132.
2
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.
World J Virol. 2022 Sep 25;11(5):375-390. doi: 10.5501/wjv.v11.i5.375.
3
Comparative diagnostic yield and 3-month outcomes of "triple rule-out" and standard protocol coronary CT angiography in the evaluation of acute chest pain.
J Cardiovasc Comput Tomogr. 2011 May-Jun;5(3):165-71. doi: 10.1016/j.jcct.2011.03.008. Epub 2011 Mar 16.
5
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Mol Biol Rep. 2021 Feb;48(2):1763-1771. doi: 10.1007/s11033-021-06148-9. Epub 2021 Jan 22.
8
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.
Circulation. 2021 Jul 27;144(4):256-266. doi: 10.1161/CIRCULATIONAHA.121.054824. Epub 2021 Apr 17.
10
Diagnostic value and key features of computed tomography in Coronavirus Disease 2019.
Emerg Microbes Infect. 2020 Dec;9(1):787-793. doi: 10.1080/22221751.2020.1750307.

本文引用的文献

1
The value of dual-energy computed tomography in the evaluation of myocarditis.
Diagn Interv Radiol. 2023 Mar 29;29(2):276-282. doi: 10.5152/dir.2022.21749. Epub 2023 Jan 27.
2
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.
World J Virol. 2022 Sep 25;11(5):375-390. doi: 10.5501/wjv.v11.i5.375.
4
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
World J Gastroenterol. 2022 Mar 21;28(11):1102-1112. doi: 10.3748/wjg.v28.i11.1102.
5
Computed tomography at every step: Long coronavirus disease.
Respir Investig. 2021 Sep;59(5):622-627. doi: 10.1016/j.resinv.2021.05.014. Epub 2021 Jun 29.
6
Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality.
Cardiol Res. 2020 Dec;11(6):398-404. doi: 10.14740/cr1159. Epub 2020 Oct 23.
7
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.
J Am Coll Cardiol. 2020 Aug 4;76(5):533-546. doi: 10.1016/j.jacc.2020.06.007. Epub 2020 Jun 8.
8
Atrial and brain natriuretic peptides: Hormones secreted from the heart.
Peptides. 2019 Jan;111:18-25. doi: 10.1016/j.peptides.2018.05.012. Epub 2018 May 31.
9
Cardiac troponin and outcome in acute heart failure.
N Engl J Med. 2008 May 15;358(20):2117-26. doi: 10.1056/NEJMoa0706824.
10
Cardiac troponins.
J Emerg Med. 2002 Jul;23(1):57-65. doi: 10.1016/s0736-4679(02)00463-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验